B. Riley Wealth Advisors’s Juno Therapeutics, Inc. JUNO Stock Holding History

B. Riley Wealth Advisors’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-6,030	Closed	-$276K	–	736
2017 Q4	$276K	Buy	+6,030	New	+$301K	0.04%	483
2015 Q1	–	Sell	-100	Closed	-$5	–	2426
2014 Q4	$5	Buy	+100	New	+$4.47K	﹤0.01%	3189

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

B. Riley Wealth Advisors's JUNO Position: Q1 2018 in Review

B. Riley Wealth Advisors sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 6,030 shares — an estimated $276K sold.

B. Riley Wealth Advisors first reported a position in JUNO in Q4 2014 and held it in 2 quarters. The position peaked at $276K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

B. Riley Wealth Advisors reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
B. Riley Wealth Advisors sold 6,030 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $276K.
B. Riley Wealth Advisors first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 2 quarters.
B. Riley Wealth Advisors's Juno Therapeutics, Inc. position peaked at $276K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2018, filed 15 May 2018.